Price movement over the last 24 hours
ARK Genomic Revolution ETF vs Flagstar Bank NA — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Flagstar Bank NA trades at $15.05 (market cap $6.29B). The key difference: Flagstar Bank NA pays a 0.27% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | FLG | |
|---|---|---|
Sector | Sector/Thematic | Financials |
52-Week High | $43.57 | $15.28 |
52-Week Low | $23.09 | $10.72 |
Market Cap | — | $6.29B |
Dividend Yield | — | 0.27% |
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Flagstar Bank (FLG) trades at $15.09, up 2.17% today, with a neutral technical outlook and bullish analyst consensus. The stock shows improving fundamentals with two consecutive quarterly earnings beats and a modest dividend. Recent news highlights technology transformation and executive leadership stability, while financial trends indicate progress toward profitability despite current negative margins.
The outlook suggests moderate upside potential with a $17.05 consensus price target, though risks include ongoing negative profitability and high interest expenses. The bank's turnaround progress and improved credit quality provide catalysts, but investors should weigh the balance between valuation discount and execution risks in the competitive banking sector.
Trailing returns across standard periods
Latest headlines on both assets
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →Flagstar Bank is a prominent US financial institution and a subsidiary of New York Community Bancorp. It provides commercial banking, mortgage services, and diverse personal finance products.
Read more on FLG →